Many pharmaceutical stocks in global markets witnessed a sharp decline in the session on September 26, following new statements by US President Donald Trump about imposing tariffs on the pharmaceutical industry.
In Europe, shares of two major pharmaceutical companies, Novo Nordisk and Zeeland Pharma, fell more than 2% in the session. Earlier, in the Asian market, the Topix Pharma index, which synthesizes Japanese pharmaceutical stocks, fell nearly 1.5%.
Major Korean and Chinese pharmaceutical companies such as Samsung Biologics and JD Health also fell by 2-5%.
In an announcement by President Donald Trump on social media, imported pharmaceutical products will be subject to a tax of up to 100% starting October 1, except for products from companies with investment projects in the US.
According to official data, the US imported nearly $233 billion worth of pharmaceuticals and medical products in 2024. The prospect of some drugs doubling in price could shock US voters as health care costs, as well as the costs of Medicare and Medicaid, are likely to rise.
Mr. Donald Trump also said that the US will impose a 25% tax on heavy trucks, a 30% tax on upholstered furniture and a 50% tax on kitchen cabinets, bathroom sinks and related products.
The announcement follows previous sweeping tariffs of up to 50% on major trading partners, as well as targeted tariffs on steel and other imports.
This escalation has clouded the outlook for global growth and added uncertainty to corporate investment decisions. The Federal Reserve has noted that these tariffs are contributing to higher prices for American consumers.
Source: https://vtv.vn/co-phieu-nganh-duoc-pham-lao-doc-do-ke-hoach-ap-thue-my-100250927062139349.htm
Comment (0)